BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?

E. Ojeda, L. Moran, P. Rodriguez, J. M. Rodriguez, S. Lopez, P. De Lucas (Madrid, Spain)

Source: International Congress 2014 – Clinical presentations
Session: Clinical presentations
Session type: Thematic Poster Session
Number: 3588
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Ojeda, L. Moran, P. Rodriguez, J. M. Rodriguez, S. Lopez, P. De Lucas (Madrid, Spain). BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity?. Eur Respir J 2014; 44: Suppl. 58, 3588

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Development of the Manchester early morning symptoms index in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014


Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Is it possible to improve the prediction ability of the BODE index?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014

COPD staging systems and BODE index
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016


Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Validity of COPD assessment test (CAT) in patients with cardiovascular co-morbidities
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013



Comorbidity at COPD - is actual problem of pulmonology
Source: International Congress 2014 – Predictors
Year: 2014


The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


The EQ5D5L in COPD: Validity, responsiveness and minimum important difference (MID)
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015


COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Comparison of CAT and CCQ in a clinical COPD population
Source: International Congress 2014 – Clinical presentations
Year: 2014

COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


Relationship between London chest daily living activity scale and i-BODE index in COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013

Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test
Source: International Congress 2014 – Clinical presentations
Year: 2014


Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013